How many of us give a “full” dose of chemotherapy to an obese patient—even in the curative setting? Dose calculation in the obese is a confusing but important puzzle for the oncologist and is becoming ...
Whether the CD34+ and CD3+ cell doses in allogeneic HSCT should be estimated using actual (ABW) or ideal (IBW) body weight has never been definitively determined. We have shown that CD34+ cell doses ...
The progenitor cell content of an allogeneic graft, which used to be measured in terms of the number of nucleated cells in the past, 1,2 is now measured in terms of the number of CD34+ cells. 3,4,5,6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results